Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.
Pandey A, Kolkailah AA, McGuire DK, Frederich RC, Cater NB, Cosentino F, Pratley RE, Dagogo-Jack S, Cherney DZI, Wynant W, Gantz I, Mancuso JP, Masiukiewicz U, Cannon CP. Pandey A, et al. Among authors: pratley re. Eur J Heart Fail. 2025 Jan 10. doi: 10.1002/ejhf.3511. Online ahead of print. Eur J Heart Fail. 2025. PMID: 39792342
Automated Insulin Delivery in Older Adults with Type 1 Diabetes.
Kudva YC, Henderson RJ, Kanapka LG, Weinstock RS, Rickels MR, Pratley RE, Chaytor N, Janess K, Desjardins D, Pattan V, Peleckis AJ, Casu A, Rizvi SR, Bzdick S, Whitaker KJ, Jo Kamimoto JL, Miller K, Kollman C, Beck RW. Kudva YC, et al. Among authors: pratley re. NEJM Evid. 2025 Jan;4(1):EVIDoa2400200. doi: 10.1056/EVIDoa2400200. Epub 2024 Dec 23. NEJM Evid. 2025. PMID: 39714936 Clinical Trial.
Long-term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.
Cosentino F, Dagogo-Jack S, Frederich R, Cannon CP, Cherney DZI, Mancuso JP, Wynant W, Xing A, Gantz I, Cater NB, Pratley RE. Cosentino F, et al. Among authors: pratley re. Diabetes Obes Metab. 2025 Feb;27(2):583-594. doi: 10.1111/dom.16050. Epub 2024 Dec 18. Diabetes Obes Metab. 2025. PMID: 39696829 Free PMC article. Clinical Trial.
Diabetes and cardiovascular disease in older adults.
Bilal A, Pratley R. Bilal A, et al. Among authors: pratley r. Ann N Y Acad Sci. 2024 Dec 12. doi: 10.1111/nyas.15259. Online ahead of print. Ann N Y Acad Sci. 2024. PMID: 39666834 Review.
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.
Badve SV, Bilal A, Lee MMY, Sattar N, Gerstein HC, Ruff CT, McMurray JJV, Rossing P, Bakris G, Mahaffey KW, Mann JFE, Colhoun HM, Tuttle KR, Pratley RE, Perkovic V. Badve SV, et al. Among authors: pratley re. Lancet Diabetes Endocrinol. 2025 Jan;13(1):15-28. doi: 10.1016/S2213-8587(24)00271-7. Epub 2024 Nov 25. Lancet Diabetes Endocrinol. 2025. PMID: 39608381
A partial loss-of-function variant (Ile191Val) of the TAS1R2 glucose receptor is associated with enhanced responses to exercise training in older adults with obesity: A translational study.
Serrano J, Kondo S, Link GM, Brown IS, Pratley RE, Baskin KK, Goodpaster BH, Coen PM, Kyriazis GA. Serrano J, et al. Among authors: pratley re. Metabolism. 2025 Jan;162:156045. doi: 10.1016/j.metabol.2024.156045. Epub 2024 Oct 10. Metabolism. 2025. PMID: 39393515 Free PMC article.
467 results